Drugs / dizocine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05532449 | Sep 2022 | — | Shanghai Zhongshan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dizocine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05532449 ↗ |
| Route | Intravenous | “Intravenous dizocine (0.03mg/kg diluted to 5 ml)” NCT05532449 ↗ |